Two Doses of Recombinant Zoster Vaccine Highly Effective
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Jan. 9, 2024 -- Two doses of recombinant zoster vaccine (RZV) are effective against herpes zoster (HZ), with the vaccine effectiveness (VE) of two doses waning little over four years of follow-up, according to a study published online Jan. 9 in the Annals of Internal Medicine.
Ousseny Zerbo, Ph.D., from Kaiser Permanente Northern California in Oakland, and colleagues conducted a prospective cohort study involving persons aged 50 years or older to evaluate the real-world effectiveness of RZV against HZ. The study included close to 2.0 million persons aged 50 years or older from four health care systems in the Vaccine Safety Datalink, with 7.6 million person-years of follow-up.
The researchers found that after adjustment, VE was 64 and 76 percent for one and two doses, respectively. After one dose only, VE was 70, 45, 48, and 52 percent during the first year, second year, third year, and after the third year, respectively. After two doses, VE was 79, 75, and 73 percent during the first, second, and third and fourth years, respectively. VE was 65 and 77 percent in those who received and did not receive corticosteroids before vaccination, respectively.
"Our finding of substantial VE among corticosteroid recipients underscores the value of vaccination for these persons, who are at increased risk for HZ," the authors write. "Our finding that the effectiveness of one dose decreased after a year further supports the current recommendation for a second dose."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-10 00:15
Read more
- Female Pediatricians Earn About 93 Percent of Male Pediatricians
- Camurus Provides Regulatory Update on the US NDA for CAM2029 in Acromegaly
- Two-Fifths of Americans Say They Experience the 'Winter Blues'
- Iowa Resident Dies of Suspected Lassa Fever After Trip to West Africa
- Lack of Insurance Could Mean Later Cancer Diagnoses for Black, Hispanic Americans
- When Is It OK to Undergo Routine Surgery After a Heart Attack?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions